Composition
- Active ingredients
- AMPHETAMINE 18.8MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- AMPHETAMINE EQ 18.8MG BASE · Tablet, orally disintegrating, extended releaseANDA209253-006 · Prescription
- AMPHETAMINE EQ 12.5MG BASE · Tablet, orally disintegrating, extended releaseANDA209253-004 · Prescription
- AMPHETAMINE EQ 6.3MG BASE · Tablet, orally disintegrating, extended releaseANDA209253-002 · Prescription
- AMPHETAMINE EQ 15.7MG BASE · Tablet, orally disintegrating, extended releaseANDA209253-005 · Prescription
- AMPHETAMINE EQ 9.4MG BASE · Tablet, orally disintegrating, extended releaseANDA209253-003 · Prescription
- AMPHETAMINE EQ 3.1MG BASE · Tablet, orally disintegrating, extended releaseANDA209253-001 · Prescription
- AMPHETAMINE 20MG · Tablet, extended releaseANDA220284-004 · Tentative approval
- AMPHETAMINE 10MG · Tablet, extended releaseANDA220284-002 · Tentative approval
- AMPHETAMINE 15MG · Tablet, extended releaseANDA220284-003 · Tentative approval
- AMPHETAMINE 6.3MG · Tablet, orally disintegratingANDA219800-002 · Tentative approval
- AMPHETAMINE 15.7MG · Tablet, orally disintegrating
At a glance
- Brand name
- Amphetamine
- Route
- Oral
- Dosage form
- Tablet, orally disintegrating
- Applicant
- Granules Pharmaceuticals Inc
- Status
- Tentative approval
- FDA approval
- 19 Dec 2025
- Application
- ANDA219800-006